XML 169 R155.htm IDEA: XBRL DOCUMENT v3.25.0.1
Net financial results (Details) - BRL (R$)
R$ in Thousands
 12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2022
Financial expenses [Abstract]      
Interest on loans, financing and debentures (1) R$ (4,453,739) R$ (3,636,730) R$ (3,648,330)
Amortization of transaction costs (2) (80,099) (67,353) (69,881)
Interest expenses on lease liabilities (3) (451,148) (441,596) (433,613)
Amortization Of Fair Value Adjustment On Business Combination (18,887)
Other (556,917) (513,483) (419,659)
Financial expenses (5,541,903) (4,659,162) (4,590,370)
Financial income [Abstract]      
Cash and cash equivalents and marketable securities 1,598,111 1,668,408 818,780
Other 139,323 157,241 148,230
Financial income 1,737,434 1,825,649 967,010
Results from derivative financial instruments [Abstract]      
Income 2,669,394 10,149,730 11,969,288
Expenses (11,782,077) (4,623,016) (5,207,721)
Derivative financial instruments, net (9,112,683) 5,526,714 6,761,567
Monetary and exchange rate variations, net [Abstract]      
Exchange rate variations on loans, financing and debentures (17,728,324) 4,185,675 3,949,020
Leases (613,124) 180,112 186,241
Other assets and liabilities (4) 2,456,455 (1,278,060) (840,668)
Monetary and exchange variations, net (15,884,993) 3,087,727 3,294,593
Net financial result (28,802,145) 5,780,928 R$ 6,432,800
Interest costs capitalised 959,968 1,160,364  
Transaction Costs for Loans and Financing   19  
Reclassification to biological assets R$ 249,135 R$ 223,055